The international collaborative study of maternal phenylketonuria

Status report 1998

R. Koch, E. Friedman, C. Azen, W. Hanley, H. Levy, Reuben Matalon, B. Rouse, F. Trefz, S. Waisbren, K. Michals-Matalon, P. Acosta, F. Guttler, K. Ullrich, L. Platt, F. De la Cruz

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

The Maternal Phenylketonuria Study began in 1984 and during the intervening years, 572 pregnancies in hyperphenylalaninemic women and 99 controls and their outcomes have been evaluated. Among hyperphenylalaninemic women who delivered a live infant, only 15.9% were treated and in metabolic control preconceptually, however, another 18.4% were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptually treated pregnancies with well controlled phenylalanine restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring, however, it did occur in 12% of pregnancies not achieving control until after 10 weeks of pregnancy. Conclusion: The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/l. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.

Original languageEnglish (US)
JournalEuropean Journal of Pediatrics, Supplement
Volume159
Issue number2
StatePublished - 2000
Externally publishedYes

Fingerprint

Maternal Phenylketonuria
Pregnancy
Phenylalanine
Microcephaly
Phenylketonurias
Heart Diseases
Diet

Keywords

  • Collaborative study
  • Maternal phenylketonuria
  • Phenylalanine

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Koch, R., Friedman, E., Azen, C., Hanley, W., Levy, H., Matalon, R., ... De la Cruz, F. (2000). The international collaborative study of maternal phenylketonuria: Status report 1998. European Journal of Pediatrics, Supplement, 159(2).

The international collaborative study of maternal phenylketonuria : Status report 1998. / Koch, R.; Friedman, E.; Azen, C.; Hanley, W.; Levy, H.; Matalon, Reuben; Rouse, B.; Trefz, F.; Waisbren, S.; Michals-Matalon, K.; Acosta, P.; Guttler, F.; Ullrich, K.; Platt, L.; De la Cruz, F.

In: European Journal of Pediatrics, Supplement, Vol. 159, No. 2, 2000.

Research output: Contribution to journalArticle

Koch, R, Friedman, E, Azen, C, Hanley, W, Levy, H, Matalon, R, Rouse, B, Trefz, F, Waisbren, S, Michals-Matalon, K, Acosta, P, Guttler, F, Ullrich, K, Platt, L & De la Cruz, F 2000, 'The international collaborative study of maternal phenylketonuria: Status report 1998', European Journal of Pediatrics, Supplement, vol. 159, no. 2.
Koch, R. ; Friedman, E. ; Azen, C. ; Hanley, W. ; Levy, H. ; Matalon, Reuben ; Rouse, B. ; Trefz, F. ; Waisbren, S. ; Michals-Matalon, K. ; Acosta, P. ; Guttler, F. ; Ullrich, K. ; Platt, L. ; De la Cruz, F. / The international collaborative study of maternal phenylketonuria : Status report 1998. In: European Journal of Pediatrics, Supplement. 2000 ; Vol. 159, No. 2.
@article{6ff96ec205644ed1adf5f26490423f6b,
title = "The international collaborative study of maternal phenylketonuria: Status report 1998",
abstract = "The Maternal Phenylketonuria Study began in 1984 and during the intervening years, 572 pregnancies in hyperphenylalaninemic women and 99 controls and their outcomes have been evaluated. Among hyperphenylalaninemic women who delivered a live infant, only 15.9{\%} were treated and in metabolic control preconceptually, however, another 18.4{\%} were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptually treated pregnancies with well controlled phenylalanine restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring, however, it did occur in 12{\%} of pregnancies not achieving control until after 10 weeks of pregnancy. Conclusion: The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/l. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.",
keywords = "Collaborative study, Maternal phenylketonuria, Phenylalanine",
author = "R. Koch and E. Friedman and C. Azen and W. Hanley and H. Levy and Reuben Matalon and B. Rouse and F. Trefz and S. Waisbren and K. Michals-Matalon and P. Acosta and F. Guttler and K. Ullrich and L. Platt and {De la Cruz}, F.",
year = "2000",
language = "English (US)",
volume = "159",
journal = "European Journal of Pediatrics, Supplement",
issn = "0943-9676",
publisher = "Springer Verlag",
number = "2",

}

TY - JOUR

T1 - The international collaborative study of maternal phenylketonuria

T2 - Status report 1998

AU - Koch, R.

AU - Friedman, E.

AU - Azen, C.

AU - Hanley, W.

AU - Levy, H.

AU - Matalon, Reuben

AU - Rouse, B.

AU - Trefz, F.

AU - Waisbren, S.

AU - Michals-Matalon, K.

AU - Acosta, P.

AU - Guttler, F.

AU - Ullrich, K.

AU - Platt, L.

AU - De la Cruz, F.

PY - 2000

Y1 - 2000

N2 - The Maternal Phenylketonuria Study began in 1984 and during the intervening years, 572 pregnancies in hyperphenylalaninemic women and 99 controls and their outcomes have been evaluated. Among hyperphenylalaninemic women who delivered a live infant, only 15.9% were treated and in metabolic control preconceptually, however, another 18.4% were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptually treated pregnancies with well controlled phenylalanine restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring, however, it did occur in 12% of pregnancies not achieving control until after 10 weeks of pregnancy. Conclusion: The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/l. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.

AB - The Maternal Phenylketonuria Study began in 1984 and during the intervening years, 572 pregnancies in hyperphenylalaninemic women and 99 controls and their outcomes have been evaluated. Among hyperphenylalaninemic women who delivered a live infant, only 15.9% were treated and in metabolic control preconceptually, however, another 18.4% were in control by 10 weeks. Compared to the results reported by Lenke and Levy in 1980, there is a marked improvement in outcome with treatment. Microcephaly was unusual in preconceptually treated pregnancies with well controlled phenylalanine restricted diets. Even in pregnancies that established control after conception but before the 8th week, congenital heart disease did not occur in the offspring, however, it did occur in 12% of pregnancies not achieving control until after 10 weeks of pregnancy. Conclusion: The recommended level of blood phenylalanine during pregnancy is 120-360 μmol/l. Best results were obtained by close cooperation between the attending obstetrician and a metabolic team experienced in the care of persons with phenylketonuria.

KW - Collaborative study

KW - Maternal phenylketonuria

KW - Phenylalanine

UR - http://www.scopus.com/inward/record.url?scp=17744414618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17744414618&partnerID=8YFLogxK

M3 - Article

VL - 159

JO - European Journal of Pediatrics, Supplement

JF - European Journal of Pediatrics, Supplement

SN - 0943-9676

IS - 2

ER -